Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Drainage fluid test may let throat cancer patients eat days earlier

NCT ID NCT06604494

Symptom relief Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether measuring certain immune markers (cytokines) in drainage fluid after throat cancer surgery can identify patients at low risk of developing a fistula (an abnormal opening). If the test shows low risk, patients may be allowed to start eating on day 3 or 4 instead of the usual day 7. The goal is to see if early feeding reduces hospital stay and improves quality of life without increasing complications. The trial will enroll 250 adults scheduled for total laryngectomy or pharyngolaryngectomy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
early feeding resumption (behavioral intervention)
What this could lead to
If successful, this could allow some throat cancer patients to start eating sooner after surgery, shortening hospital stays and improving quality of life without increasing fistula risk.
What could go wrong
This is a relatively small, early-phase study. The cytokine test may not reliably predict fistula risk, and early feeding could still lead to complications in some patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 250 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patient with cancer requiring a total laryngectomy or pharyngolaryngectomy scheduled after multidisciplinary consultation. * Holder of a social security scheme Exclusion Criteria: Pregnant and breastfeeding women Persons under curatorship, guardianship, legal protection or deprived of liberty Any medical condition deemed by the investigator to be incompatible with the study. Refusal to participate. Body mass index less than 18.5 kg/ m2 \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer, otorhinolaryngeal are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

head and neck cancer Otorhinolaryngologic Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer, otorhinolaryngeal

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    7 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH Emile Roux

    NOT_YET_RECRUITING

    Le Puy-en-Velay, France

  • CH de Valence

    NOT_YET_RECRUITING

    Valence, France

  • CHU de Clermont-Ferrand

    RECRUITING

    Clermont-Ferrand, France

  • CHU de Grenoble

    NOT_YET_RECRUITING

    Grenoble, France

  • CHU de Saint-Etienne

    NOT_YET_RECRUITING

    Saint-Etienne, France

  • HCL Hôpital Croix Rousse

    NOT_YET_RECRUITING

    Lyon, France

  • Institut Gustave Roussy

    NOT_YET_RECRUITING

    Villejuif, France